Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Animal Reproduction Science
|
August 4, 2005
Pregnancy rates and gravid uterine parameters in single, twin and triplet pregnancies in naturally bred ewes and ewes after transfer of in vitro produced embryos
Anna T Grazul-Bilska, Disha Pant, Justin S Luther, et al.
Neurology
|
February 19, 2000
Seizure outcome after temporal lobectomy for temporal lobe epilepsy: a Kaplan-Meier survival analysis
N Foldvary, B Nashold, E Mascha, et al.
Journal of Animal Science
|
July 27, 2010
Ovine offspring growth and diet digestibility are influenced by maternal selenium supplementation and nutritional intake during pregnancy despite a common postnatal diet
T L Neville, J S Caton, C J Hammer, et al.
Anti-Cancer Drugs
|
August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators
K A Havlin, J G Kuhn, J B Craig, et al.
Reproduction (Cambridge, England)
|
January 24, 2009
Fetoplacental growth and vascular development in overnourished adolescent sheep at day 50, 90 and 130 of gestation
Dale A Redmer, Justin S Luther, John S Milne, et al.
Epilepsy Research. Supplement
|
January 1, 1992
Inhibitory and excitatory amino acid receptors, c-fos expression, and calcium-binding proteins in the brain of baboons (Papio hamadryas) that exhibit 'spontaneous' grand mal epilepsy
M K Ticku, J C Lee, S Murk, et al.
The International Journal of Developmental Biology
|
November 20, 2009
Uteroplacental vascular development and placental function: an update
Lawrence P Reynolds, Pawel P Borowicz, Joel S Caton, et al.
Journal of Animal Science
|
December 22, 2009
Developmental programming: the concept, large animal models, and the key role of uteroplacental vascular development
L P Reynolds, P P Borowicz, J S Caton, et al.
Selective Cancer Therapeutics
|
January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule
P W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Animal Reproduction Science
|
August 4, 2005
Pregnancy rates and gravid uterine parameters in single, twin and triplet pregnancies in naturally bred ewes and ewes after transfer of in vitro produced embryos
Anna T Grazul-Bilska, Disha Pant, Justin S Luther, et al.
Neurology
|
February 19, 2000
Seizure outcome after temporal lobectomy for temporal lobe epilepsy: a Kaplan-Meier survival analysis
N Foldvary, B Nashold, E Mascha, et al.
Journal of Animal Science
|
July 27, 2010
Ovine offspring growth and diet digestibility are influenced by maternal selenium supplementation and nutritional intake during pregnancy despite a common postnatal diet
T L Neville, J S Caton, C J Hammer, et al.
Anti-Cancer Drugs
|
August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators
K A Havlin, J G Kuhn, J B Craig, et al.
Reproduction (Cambridge, England)
|
January 24, 2009
Fetoplacental growth and vascular development in overnourished adolescent sheep at day 50, 90 and 130 of gestation
Dale A Redmer, Justin S Luther, John S Milne, et al.
Epilepsy Research. Supplement
|
January 1, 1992
Inhibitory and excitatory amino acid receptors, c-fos expression, and calcium-binding proteins in the brain of baboons (Papio hamadryas) that exhibit 'spontaneous' grand mal epilepsy
M K Ticku, J C Lee, S Murk, et al.
The International Journal of Developmental Biology
|
November 20, 2009
Uteroplacental vascular development and placental function: an update
Lawrence P Reynolds, Pawel P Borowicz, Joel S Caton, et al.
Journal of Animal Science
|
December 22, 2009
Developmental programming: the concept, large animal models, and the key role of uteroplacental vascular development
L P Reynolds, P P Borowicz, J S Caton, et al.
Selective Cancer Therapeutics
|
January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule
P W Cobb, K A Havlin, J G Kuhn, et al.
Cancer Research
|
August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule
G S Harman, J B Craig, J G Kuhn, et al.
Page
of 8